Jss medical research montreal

Recognized as a leading clinical epidemiologist and one of the top trauma researchers in Canada, he possesses extensive expertise in health services research, jss medical research montreal trials, and offers services as a Research and Epidemiological Consultant for numerous pharmaceutical companies, hospitals and government organizations and agencies. Watson holds a M. Her experience extends to all facets of the CRO business, and multiple therapeutic areas.

Additional regional offices are located in Ahmedabad, Bangalore, Chennai and Mumbai. For our biotech clients the expansion will provide them with access to patients and high quality research sites that will facilitate the completion of their clinical development programs. This is an important step for JSS Medical Research in its evolution as a niche global CRO and a major achievement for the Canadian and Quebec Health Care Research Industry because it is testimony to the fact that the quality and value of the scientific work done here transcends geographic borders and limits. John S. The company employs approximately highly trained individuals the majority of which are physicians or other health care professionals. It provides full range of services including project management, data management, clinical trial supplies management, regulatory services and medical writing.

Jss medical research montreal

Theralase anticipates executing further agreements in the Quebec biotech sector worth several million dollars over the next 12 to 18 months. Internationally, there are , new cases a year. Risk factors for bladder cancer increasingly are being linked to smoking, as countries with a higher prevalence of smoking have demonstrated higher rates of bladder cancer. Theralase has discovered a treatment that destroys cancer cells and prevents their reoccurrence during preclinical testing and is quickly advancing to human clinical trials. The Globe and Mail reported on September 8, that Canada is experiencing a serious shortage of an essential drug for the treatment of bladder cancer. The shortfall, which is due to manufacturing problems at plants operated by two different pharmaceutical companies, could have major consequences for patients. If Theralase is successful in its human clinical trials in bladder cancer, this may help to alleviate the reliance on BCG. Theralase chose to partner with JSS for several reasons. First and foremost, JSS has built its reputation on the successful design, execution, analysis and publication of FDA and Health Canada-approved human clinical trials. The recent merger with Integrated Research Inc.

Theralase intends to continue to invest in the Quebec biotech market as the research and development progresses and if this research is successful, Theralase plans to invest millions of dollars into the. Our Laser Systems.

Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry. Policy Get Involved. Join BIOAction. View Advocacy Toolkit. Patient Advocacy.

For Businesses. Find the best places and services. See more. Magazine , Newspaper , Bookmaker's offices , Passenger automobile and electric transport enterprises , Publishing house , Cloth wholesaler , IT Consulting. Country club.

Jss medical research montreal

Skip to main content. Published: May 10, This clinical service portfolio addition will enable the GD 3 member companies to expand their full-service drug research and discovery services. JSS Medical Research's skilled team of world-class scientists will work synergistically and augment GD 3 's existing platform of services in clinical trial support, including clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, biostatistics and medical writing, medical monitoring, safety reporting, and project management for the development and approval of pharmaceutical, nutraceutical and medical device products. The merger of the two companies creates an organization that will deliver state-of-the-art scientific support and services to our combined and growing list of pharmaceutical, biotechnology and medical device clients. As one entity, we will be able to conveniently support our clients throughout the drug development life cycle, including discovery, epidemiological, pre-clinical, clinical, post-marketing, health economics and real-world evidence. For the management and employees of JSS, this is an exciting next phase in the evolution of our company that will accelerate our access to new markets both geographically and in our service offerings. We are all delighted to be part of GD3 and are committed to creating a unique health research organization that will set new standards in the industry," stated Dr. John S.

Ingilizce mutlu hafta sonları

Policy Get Involved. BIO Events. Health Blog. For more information, visit www. Dr Machado obtained his medical degree from the University of Pune, India. It is mandatory to procure user consent prior to running these cookies on your website. You also have the option to opt-out of these cookies. Risk factors for bladder cancer increasingly are being linked to smoking, as countries with a higher prevalence of smoking have demonstrated higher rates of bladder cancer. Our History. All Events. Amicus Briefs. John S. Theralase intends to continue to invest in the Quebec biotech market as the research and development progresses and if this research is successful, Theralase plans to invest millions of dollars into the. Watson holds a M.

This clinical service portfolio addition will enable the GD 3 member companies to expand their full-service drug research and discovery services. The merger of the two companies creates an organization that will deliver state-of-the-art scientific support and services to our combined and growing list of pharmaceutical, biotechnology and medical device clients.

Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry. Cool Laser Therapy — Patients. Strengthening the Bioeconomy. Biotech Jobs. Healthcare Practitioners. Clinical Studies. Sampalis, Ph. The Company disclaims any obligation to update these forward-looking statements. Boukas has been essential in structuring and implementing programs at JSS Medical Research Inc to facilitate project management, site recruitment, data capture and study tracking. Patient Advocacy. TLC Laser Series. Save with BIO. Necessary Necessary.